Home › Funds › 683 Capital Management, LLC › MRNA
683 Capital Management, LLC position in MRNA
MODERNA INC · Health Care
683 Capital Management, LLC reported holding 181,000 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$34.9M, representing 1.55% of its reported portfolio and ranking #15 among its reported holdings. 683 Capital Management, LLC has disclosed MRNA holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How 683 Capital Management, LLC's MRNA position evolved
683 Capital Management, LLC first disclosed a stake in MRNA in Q3 2023 at 15,000 shares (US$1.5M). The position peaked in Q3 2026 at 181,000 shares, worth US$34.9M. Across 7 filings, 683 Capital Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 181,000 shares valued at US$34.9M — an increase of 25,000 shares quarter over quarter.. Notable position changes include a 31% increase in Q3 2024 (shares fell 38% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 15.00K | $1.55M | New |
| Q4 2023 | 15.00K | $1.49M | Hold |
| Q2 2024 | 28.63K | $3.40M | New |
| Q3 2024 | 37.50K | $2.51M | Add |
| Q1 2026 | 156.00K | $7.92M | New |
| Q2 2026 | 156.00K | $10.92M | Hold |
| Q3 2026 | 181.00K | $34.86M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 45 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Fidelity Management & Research (FMR) 58.96M sh · $11.35B · Q3 2026
- Capital World Investors 22.64M sh · $4.36B · Q3 2026
- Baillie Gifford & Co 11.44M sh · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M sh · $1.28B · Q3 2026
- IMC-Chicago, LLC 3.07M sh · $590.92M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- a16z Perennial Management, L.P. 1.52M sh · $292.57M · Q3 2026
- BAMCO INC /NY/ 1.39M sh · $267.88M · Q3 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
More on 683 Capital Management, LLC
FAQ
How long has 683 Capital Management, LLC held MRNA?
683 Capital Management, LLC has disclosed MRNA holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
What is 683 Capital Management, LLC's current position in MRNA?
As of Q3 2026, 683 Capital Management, LLC holds 181.00K shares of MRNA (MODERNA INC), valued at $34.86M, representing 1.55% of its reported portfolio and ranking #15.
Has 683 Capital Management, LLC been buying or selling MRNA?
In the latest 13F filing (Q3 2026), 683 Capital Management, LLC increased its position in MRNA. The position peaked in Q3 2026 at 181.00K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.